Shinva Medical InstrumentLtd Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Shinva Medical InstrumentLtd şirketinin toplam hissedar öz sermayesi CN¥7.9B ve toplam borcu CN¥1.1B olup, bu da borç-öz sermaye oranını 13.5% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥15.4B ve CN¥7.5B dir. Shinva Medical InstrumentLtd 'in FAVÖK'ü CN¥712.6M faiz karşılama oranı -10.8 dur. Şirketin CN¥2.5B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

13.5%

Borç/özkaynak oranı

CN¥1.06b

Borç

Faiz karşılama oranı	-10.8x
Nakit	CN¥2.52b
Eşitlik	CN¥7.90b
Toplam yükümlülükler	CN¥7.49b
Toplam varlıklar	CN¥15.39b

Son finansal sağlık güncellemeleri

Is Shinva Medical InstrumentLtd (SHSE:600587) Using Too Much Debt?

Aug 08

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Apr 22

Recent updates

Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Business And Shares Still Trailing The Market

Jul 18

Does This Valuation Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Imply Investors Are Overpaying?

Jun 07

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Apr 22

Shinva Medical InstrumentLtd's (SHSE:600587) Returns On Capital Not Reflecting Well On The Business

Mar 28

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 600587 'nin kısa vadeli varlıkları ( CN¥9.4B ) kısa vadeli yükümlülüklerini ( CN¥7.1B ) aşıyor.

Uzun Vadeli Yükümlülükler: 600587 şirketinin kısa vadeli varlıkları ( CN¥9.4B ) uzun vadeli yükümlülüklerini ( CN¥350.9M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 600587 şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: 600587 'nin borç/öz sermaye oranı son 5 yılda 82.5% seviyesinden 13.5% seviyesine düştü.

Borç Kapsamı: 600587 'nin borcu işletme nakit akışı ( 66.4% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: 600587 ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.

Shinva Medical InstrumentLtd Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is Shinva Medical InstrumentLtd (SHSE:600587) Using Too Much Debt?

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.22 (vs CN¥0.20 in 3Q 2023)

Now 23% undervalued

Estimating The Fair Value Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587)

Shinva Medical Instrument Co.,Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 20%

Returns At Shinva Medical InstrumentLtd (SHSE:600587) Are On The Way Up

Second quarter 2024 earnings released: EPS: CN¥0.74 (vs CN¥0.43 in 2Q 2023)

Is Shinva Medical InstrumentLtd (SHSE:600587) Using Too Much Debt?

Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Business And Shares Still Trailing The Market

Now 19% overvalued

Shinva Medical Instrument Co.,Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Now 22% overvalued

Does This Valuation Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Imply Investors Are Overpaying?

Investor sentiment deteriorates as stock falls 17%

Dividend increased to CN¥0.50

First quarter 2024 earnings released: EPS: CN¥0.45 (vs CN¥0.46 in 1Q 2023)

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Full year 2023 earnings: EPS and revenues miss analyst expectations

Shinva Medical Instrument Co.,Ltd., Annual General Meeting, Apr 18, 2024

Shinva Medical InstrumentLtd's (SHSE:600587) Returns On Capital Not Reflecting Well On The Business

Investor sentiment deteriorates as stock falls 19%

Shinva Medical Instrument Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024

Third quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.24 in 3Q 2022)

Shinva Medical Instrument Co.,Ltd. to Report Q3, 2023 Results on Oct 25, 2023

Second quarter 2023 earnings released: EPS: CN¥0.57 (vs CN¥0.48 in 2Q 2022)

New minor risk - Dividend sustainability

Full year 2022 earnings released: EPS: CN¥1.23 (vs CN¥1.37 in FY 2021)

Investor sentiment improves as stock rises 17%

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.24 (vs CN¥0.27 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.48 (vs CN¥0.45 in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased to CN¥41.65

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.27 (vs CN¥0.20 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.45 (vs CN¥0.25 in 2Q 2020)

Investor sentiment improved over the past week

Zou Huiling acquired 16.67% stake in Beijing Huaco Healthcare Technologies Co., Ltd. from Shinva Medical Instrument Co., Ltd. (SHSE:600587) for CNY 25 million.

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.36 (vs CN¥0.08 in 1Q 2020)

New 90-day low: CN¥12.23

New 90-day low: CN¥13.25

New 90-day low: CN¥14.41

New 90-day low: CN¥14.78

New 90-day low: CN¥15.88

Third quarter earnings released

Shinva Medical Instrument Co., Ltd. to Report Q3, 2020 Results on Oct 31, 2020

First half earnings released

Nanyang Great Health Medical Care Industry Development Co., Ltd acquired 80% stake in Nanyang Orthopedics High-tech Zone Hospital Co., Ltd. from Shinva Medical Instrument Co., Ltd. (SHSE:600587) for CNY 53.8 million.

New 90-day high - CN¥18.41

Shinva Medical Instrument Co., Ltd. to Report First Half, 2020 Results on Aug 29, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin